home / stock / aezs / aezs quote
Last: | $1.95 |
---|---|
Change Percent: | -0.43% |
Open: | $1.965 |
Close: | $1.95 |
High: | $1.965 |
Low: | $1.95 |
Volume: | 5,030 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.95 | $1.965 | $1.95 | $1.965 | $1.95 | 5,030 | 04-19-2024 |
$1.9566 | $1.95 | $1.9566 | $1.96 | $1.95 | 5,438 | 04-18-2024 |
$1.98 | $1.95 | $1.98 | $1.98 | $1.95 | 896 | 04-17-2024 |
$1.95 | $1.95 | $1.95 | $1.99 | $1.95 | 29,557 | 04-16-2024 |
$1.96 | $1.97 | $1.96 | $2.01 | $1.96 | 5,967 | 04-15-2024 |
$1.975 | $2.04 | $1.975 | $2.07 | $1.975 | 12,437 | 04-12-2024 |
$2.07 | $2.07 | $2.07 | $2.07 | $2.05 | 1,348 | 04-11-2024 |
$2.045 | $2.07 | $2.045 | $2.09 | $1.9727 | 27,955 | 04-10-2024 |
$2.08 | $2.06 | $2.08 | $2.08 | $2.05 | 8,702 | 04-09-2024 |
$2.06 | $1.98 | $2.06 | $2.09 | $1.98 | 8,962 | 04-08-2024 |
$2.02 | $2.26 | $2.02 | $2.26 | $1.95 | 36,306 | 04-05-2024 |
$2.08 | $2.08 | $2.08 | $2.15 | $2.07 | 5,248 | 04-04-2024 |
$2.1 | $2.1243 | $2.1 | $2.1282 | $2.088 | 4,076 | 04-03-2024 |
$2.1119 | $2.03 | $2.1119 | $2.18 | $2.02 | 9,559 | 04-02-2024 |
$2.09 | $2.12 | $2.09 | $2.19 | $2.09 | 19,127 | 04-01-2024 |
$2.19 | $2.05 | $2.19 | $2.19 | $2.01 | 49,615 | 03-29-2024 |
$2.19 | $2.05 | $2.19 | $2.19 | $2.01 | 49,615 | 03-28-2024 |
$2.08 | $1.97 | $2.08 | $2.1 | $1.97 | 22,949 | 03-27-2024 |
$2 | $1.98 | $2 | $2.09 | $1.98 | 9,059 | 03-26-2024 |
$1.99 | $1.99 | $1.99 | $2.08 | $1.99 | 4,236 | 03-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Aeterna Zentaris Inc. Company Name:
AEZS Stock Symbol:
NASDAQ Market:
TORONTO and EDMONTON, Alberta, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) ("Aeterna") and Ceapro ...
TORONTO and EDMONTON, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (" Aeterna ") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“ Ceapro ”) are pleased to announce that the Court of King's Bench of Alberta has issued a final order approvin...
- Company confirms successful completion of enrollment in the pivotal DETECT Phase 3 trial - Company ended the year with $34.0 million in cash, expected to fund operations through 2024 and into 2025 - All-stock merger of equals transaction with Ceapro, Inc. expected to close i...